Works matching IS 02724391 AND DT 2004 AND VI 61 AND IP 4
Results: 6
Characterization of the anti?platelet actions of FK419, a novel non?peptide antagonist of platelet GPIIb/IIIa.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 233, doi. 10.1002/ddr.10382
- By:
- Publication type:
- Article
Northern ring conformation of methanocarba?adenosine 5??triphosphate required for activation of P2X receptors.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 227, doi. 10.1002/ddr.10381
- By:
- Publication type:
- Article
Effects of a new 1,3,4?thiadiazolium mesoionic compound, MI?D, on the acute inflammatory response.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 207, doi. 10.1002/ddr.10354
- By:
- Publication type:
- Article
Pharmacodynamic differences between species exemplified by the novel anticancer agent CHS 828.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 218, doi. 10.1002/ddr.10353
- By:
- Publication type:
- Article
Augmentation of all?trans?retinoic acid concentration in plasma by preventing inflammation responses induced by atRA?loaded microspheres with concurrent treatment of dexamethasone.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 197, doi. 10.1002/ddr.10349
- By:
- Publication type:
- Article
Inhibitory effects of novel tetrahydropyridine derivatives on nitric oxide and reactive oxygen species production in glioma cells.
- Published in:
- Drug Development Research, 2004, v. 61, n. 4, p. 189, doi. 10.1002/ddr.10342
- By:
- Publication type:
- Article